Effectual Labeling of Natural Killer Cells with Upconverting Nanoparticles by Electroporation for In Vivo Tracking

Hye Sun Park1, Jongwoo Kim2,3, Mi Young Cho1

  • 1Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Cheongju 28119, Korea.

Insights

Researchers developed a novel method to label natural killer (NK) cells for cancer immunotherapy. This technique enables effective tracking of these immune cells in vivo, advancing their therapeutic applications.

Area of Science:

  • Immunology
  • Biotechnology
  • Nanotechnology

Background:

  • Natural killer (NK) cells are crucial cytotoxic lymphocytes in innate immunity and show promise for cancer immunotherapy.
  • Evaluating NK cell biodistribution and pharmacokinetics after systemic administration is essential for therapeutic development.
  • The limited phagocytic capacity of NK cells poses challenges for efficient cell labeling and in vivo tracking.

Purpose of the Study:

  • To develop an effective method for labeling NK cells with upconverting nanoparticles (UCNPs) for in vivo imaging and tracking.
  • To optimize electroporation conditions for high-sensitivity and stable UCNP labeling of NK cells.
  • To analyze the biodistribution and pharmacokinetics of UCNP-labeled NK cells following intravenous injection.

Main Methods:

  • Electroporation was employed to introduce UCNPs into NK cells, with varying PEGylation strategies (carboxy-PEG, methoxy-PEG, amine-PEG) investigated.
  • Optimization of electroporation parameters (electric field strength) was performed to balance labeling efficiency and cell viability.
  • In vivo imaging and biodistribution studies were conducted after intravenous injection of UCNP-labeled NK cells in a preclinical model.

Main Results:

  • Carboxy-PEG functionalized UCNPs demonstrated superior labeling performance compared to other PEGylation methods.
  • An optimal electroporation condition was identified, maximizing UCNP internalization while minimizing NK cell damage.
  • Biodistribution analysis revealed initial accumulation of labeled NK cells in the lungs, followed by distribution to the liver and spleen.

Conclusions:

  • Electroporation provides an effective strategy for high-sensitivity and stable labeling of NK cells with UCNPs.
  • Optimized UCNP labeling facilitates in vivo tracking and biodistribution assessment of NK cells for immunotherapy.
  • These advancements are expected to accelerate the clinical application of NK cell-based cancer immunotherapies.

Related Concept Videos